Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer.
about
Anastrozole-related acute hepatitis with autoimmune features: a case report.Patterns of bone density evaluation in a community population treated with aromatase inhibitors.Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancerp53 accumulation is a strong predictor of recurrence in estrogen receptor-positive breast cancer patients treated with aromatase inhibitors.Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy.Early breast cancer in the older woman.Prognostic impact of progesterone receptor status combined with body mass index in breast cancer patients treated with adjuvant aromatase inhibitor.Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole.A case of synchronous bilateral breast cancer with different pathological responses to neoadjuvant chemotherapy with different biological character.Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study.Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients.The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy.Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor.Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients.Patient and physician perceptions on continuing aromatase inhibitors beyond the 5-year mark.Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer.How estrogen fuels breast cancer.
P2860
Q33859044-300241A5-A798-4F78-AA8A-937B802CCAE3Q34335213-5452F851-8F77-409E-A4D8-F066DEF937ACQ34725685-D5D73120-A90F-4137-BA9D-51A41F8F61FCQ35051755-4DBE1091-EE09-443B-999F-189B9AE6E6C9Q35115629-9C6ABCB1-7386-49AE-8AB1-28C4874A98F9Q35159751-DDED8A17-6652-4BCE-A7C1-43F23B5FE178Q35584539-C60901A2-D29A-40AA-B5F8-15681A20381AQ36334705-B2EEE943-C931-4639-B8E7-C86DDAEB61FAQ36740503-48153DFB-723A-49B3-9DE1-4A6337CB7233Q36965404-55A0605A-4344-4164-8782-10D85743203BQ37182310-37D35D14-F7A8-45B2-8BB9-382FDF7B9024Q37277121-2B7C9A3E-7908-4643-B206-D5FE8BB8C724Q37362696-D879E603-0D4A-4983-9B76-1A0CDD70C65EQ38003702-F18180F5-61E0-4855-8A2D-AFE490BC4BE1Q38349784-B4330DC8-9E68-4647-80AD-F7D93D17ED50Q40503471-14AA7496-FCBC-4CD1-86EC-9E060296ED31Q43627047-08BD2CB0-C677-460B-B0B4-DB4501ACD203Q47941822-88D3672C-086A-4938-A93E-8B07455E0208Q51789346-0E7A8A3C-DF49-49A1-A478-42B00CE22F83
P2860
Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current topics and perspective ...... he treatment of breast cancer.
@en
Current topics and perspective ...... he treatment of breast cancer.
@nl
type
label
Current topics and perspective ...... he treatment of breast cancer.
@en
Current topics and perspective ...... he treatment of breast cancer.
@nl
prefLabel
Current topics and perspective ...... he treatment of breast cancer.
@en
Current topics and perspective ...... he treatment of breast cancer.
@nl
P1433
P1476
Current topics and perspective ...... he treatment of breast cancer.
@en
P2093
Hirotaka Iwase
P2888
P304
P356
10.1007/S12282-008-0071-Y
P577
2008-09-23T00:00:00Z